Poland· PL-100370165

Abacavir + Lamivudine Sandoz

A lamivudine and abacavir product containing abacavirum + lamivudinum, registered in Poland by Sandoz GmbH. The same ATC class is registered in 14 of our 19 countries.

ATC J05AR02

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about abacavirum + lamivudinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lamivudine and abacavir is registered in 14 of 19 countries.

Countries holding a registration under ATC J05AR02 (lamivudine and abacavir), each read from that country’s own register.

This record: Poland, from URPL (Poland)
9 of them publish a price we can compare per daily dose

Search lamivudine and abacavir products by name

Lamivudine and abacavir · ATC J05AR02

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)

Active substance: Abacavirum + Lamivudinum
Manufacturer: Sandoz GmbH
Country: Poland (PL)
ATC code: J05AR02
ATC class: Lamivudine and abacavir
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 4

gtin
05907626706420
gtin
05907626706451
gtin
05907626706437
gtin
05907626706444

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for lamivudine and abacavir.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lamivudine and abacavir against other medicines How interaction checks work

Lamivudine and abacavir · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Lamivudine and abacavir in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lamivudine and abacavir products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Abacavir/Lamivudin Ratiopharm, Abacavir/Lamivudin Sandoz
Belgium · Abacavir/Lamivudine Viatris
Bulgaria · Abacavir/Lamivudine Viatris, Абакавир/Ламивудин Майлан
Cyprus · Kivala
Germany · Abacavir/Lamivudin Al, Abacavir/Lamivudin Aurobindo
Denmark · Abacavir/Lamivudin Medical Valley, Abacavir/Lamivudin Mylan
Estonia · Abacavir/Lamivudine Auxilia, Abacavir/Lamivudine Mylan
Spain · Abacavir/Lamivudina Aurovitas, Abacavir/Lamivudina Dr. Reddys
Finland · Abacavir/Lamivudin Mylan, Abacavir/Lamivudin Viatris
France · Abacavir / Lamivudine Biogaran, Abacavir/Lamivudine Arrow
United Kingdom (Northern Ireland) · Abacavir/Lamivudin Sandoz, Abacavir/Lamivudine Accord
Greece · Abacavir+lamivudine Mylan Pharma, Varistren
Hungary · Abacavir/Lamivudine Teva
Ireland · Abacavir/Lamivudine Mylan, Abacavir/Lamivudine Viatris
Iceland · Kivexa
Italy · Abacavir E Lamivudina Aurobindo, Abacavir E Lamivudina Sun
Liechtenstein · Kivexa
Lithuania · Abacavir / Lamivudine Auxilia, Abacavir/Lamivudine Accord
Luxembourg · Abacavir/Lamivudine Viatris
Latvia · Abacavir/Lamivudine Accord, Abacavir/Lamivudine Mylan
Netherlands · Abacavir Sulfate / Lamivudine Aurobindo, Abacavir/Lamivudin Teva
Norway · Abacavir/Lamivudin Mylan, Abacavir/Lamivudine Viatris
Portugal · Abacavir + Lamivudina Aurovitas, Abacavir + Lamivudina Farmoz
Romania · Abacavir/Lamivudină, Abacavir/Lamivudină Mylan
Sweden · Abacavir/Lamivudine Accord, Abacavir/Lamivudine Glenmark

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/9e4add91-dbff-43ca-9994-5f36edbf3dd5
GET /v1/drugs/9e4add91-dbff-43ca-9994-5f36edbf3dd5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "600 mg + 300 mg",
  "packaging": "05907626706420 ¦ Rpz ¦ 117901\n30 tabl. w blistrze\n05907626706451 ¦ Rpz ¦ 117902\n1 butelka 30 tabl.\n05907626706437 ¦ Rpz ¦ 117903\n60 tabl.\n05907626706444 ¦ Rpz ¦ 117904\n90 tabl.",
  "substance": "Abacavirum 600 mg + Lamivudinum 300 mg",
  "common_name": "Abacavirum + Lamivudinum",
  "pl_product_id": "100370165",
  "pozwolenie_nr": "23445",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about lamivudine and abacavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console